MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose V...
FDA Recall #D-0370-2022 — Class II — December 31, 2021
Product Description
MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 16714-090-01, packaged in cartons.
Reason for Recall
Lack of Assurance of Sterility
Recalling Firm
Teva Pharmaceuticals USA — Parsippany, NJ
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
7,400 cartons
Distribution
Methylprednisolone, TN Norepinephrine BItartrate - MS, OH
Code Information
Lot # 100022393, exp 09/2022
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated